Status:
COMPLETED
Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture
Lead Sponsor:
Kalpna Kay Durairaj, MD, FACS
Collaborating Sponsors:
Evolus, Inc.
Conditions:
Skin Aging
Skin Wrinkling
Eligibility:
FEMALE
18-65 years
Phase:
PHASE1
Brief Summary
The goal of this split-face clinical trial is to test the efficacy of microtox in improving facial skin quality, fine wrinkles, and texture. Participants will: * be randomly assigned to Group A (whic...
Detailed Description
Twenty (20) subjects will be enrolled in the study. The subjects will have one treatment session at week 0, and two live assessment visits at weeks 2 and 12. Office visits will last approximately 2 ho...
Eligibility Criteria
Inclusion
- Biological females, 18-65 years old, of any race and ethnic background
- Individuals with mild to moderate facial wrinkles
- All skin types (Fitzpatrick I-VI)
- Willingness to participate and provide written informed consent
- Ability to follow study instructions and likely to complete all required visits
Exclusion
- Females who are pregnant, breastfeeding, chronically using nonsteroidal anti-inflammatory drugs, have autoimmune conditions or have a known allergy to the study medications.
- Previous cosmetic procedures near the forehead within the last 6 months or botulinum toxin treatments within the last 4 months
- Known neuromuscular disorders or a hypersensitivity to botulinum toxin
- Significant dermatological conditions affecting the face
- Use of medications affecting neuromuscular function or skin healing within 2 weeks prior to the beginning of study
- Subject has a condition or is in a situation which, in the opinion of the Investigator, may put the subject at significant risk, may confound the study results, or may interfere significantly with participation in the study.
Key Trial Info
Start Date :
September 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 16 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06604832
Start Date
September 3 2024
End Date
September 16 2025
Last Update
October 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
K. Kay Durairaj, MD, A Medical Corp.
Pasadena, California, United States, 91105